Incyte Corporation
USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS

Last updated:

Abstract:

The present application provides methods of treating PI3K.delta. related disorders using compounds of Formula I: ##STR00001## or pharmaceutically acceptable salts thereof.

Status:
Application
Type:

Utility

Filling date:

30 Jun 2021

Issue date:

21 Apr 2022